Moody's has upgraded Italy's debt outlook to stable from negative, leaving the sovereign debt rating at Baa3. This unexpected boost for Prime Minister Giorgia Meloni's government comes amid Bayer facing multiple setbacks. Bayer has been ordered to pay $1.56 billion in a US trial over Roundup weedkiller, and its blood-thinner drug trial was halted, leading to a lowered outlook by Moody’s. The company also faced a $165 million verdict over PCBs in a Seattle school.
Bayer had its outlook lowered to negative from stable by Moody’s after a series of drug pipeline and legal setbacks that have sent its shares and bonds tumbling https://t.co/0ERyQ7mfN0
Bayer had its outlook lowered to negative from stable by Moody’s after a series of drug pipeline and legal setbacks that have sent its shares and bonds tumbling https://t.co/eqKyfKVzAL
Bayer said it didn’t know the results of its blood-thinner drug trial, which was halted this week, before selling $5.75 billion of bonds to investors https://t.co/2dut3lHBS4
Bayer said it didn’t know the results of its blood-thinner drug trial, which was halted this week, before selling $5.75 billion of bonds to investors https://t.co/DAB1OwjvbO
MONSANTO HIT WITH $165 MILLION VERDICT OVER PCBS IN SEATTLE SCHOOL (Reuters) A U.S. jury has ordered Bayer's Monsanto to pay $165 million to employees of a school northeast of Seattle who claimed chemicals made by the company called polychlorinated biphenyls, or PCBs, leaked… https://t.co/wmhI5qXkiq
⚠️ MONSANTO HIT WITH $165 MILLION VERDICT OVER PCBS IN SEATTLE SCHOOL Full Story → https://t.co/9syNkVKcpX A U.S. jury has ordered Bayer's Monsanto to pay $165 million to employees of a school northeast of Seattle who claimed chemicals made by the company called…
Bayer's blood thinner fails Eliquis test, sinking phase 3 trial and denting $5B sales forecast https://t.co/aeJQGovcVr
$BMY (-4.6% pre) Bristol Myers slumps as Bayer trial failure casts doubt on $5 billion drug - TheStreet https://t.co/m2onnFSDGN
Bayer halts trial of blood thinner drug due to ineffectiveness, facing significant setback https://t.co/LyjHawo4n7 https://t.co/WGzppxZtWr
Bristol Myers slumps as Bayer trial failure casts doubt on $5 billion drug https://t.co/ojMgivtkOE
Drugmaker Bayer Stock Drops to Lowest Since 2009 as Blood Thinner Trial Fails https://t.co/45O4SnSKiE
Bayer shares plunge after blood-thinning drug trial halted https://t.co/u2TTRKn2dB
Bayer faces two fresh setbacks after stopping the main study of its top experimental medicine and losing a key US trial against its weed killer Roundup https://t.co/oYuZe7y9yb
🔴 MOODY'S REVISES SOFTBANK'S OUTLOOK TO STABLE FROM NEGATIVE.
🟧 Bayer ordered to pay $1.56 billion in latest US trial loss over Roundup weedkiller A Missouri jury ordered Bayer to pay $1.56 billion to four plaintiffs who claimed the company's Roundup weedkiller caused injuries including cancer, a verdict that could intensify investor… https://t.co/0L1iAQJPbj https://t.co/ZetMgushzl
Bayer ordered to pay $1.56 billion in latest US trial loss over Roundup weedkiller https://t.co/30lTmXyuZb https://t.co/IDfZO0f6tu
Bayer's Monsanto Hit With $1.5 Billion Verdict in Latest Roundup Cancer Case https://t.co/dRbWpOTUBB
MOODY'S LIFTS ITALY'S DEBT OUTLOOK TO STABLE (Reuters) Moody's on Friday left Italy's sovereign debt rating at Baa3, one notch above junk, but upgraded the outlook to stable from negative, in an unexpected boost for Prime Minister Giorgia Meloni's government. https://t.co/IFQIM0H89D
🇮🇹 Moody's lifts Italy's debt outlook to stable in boost for Meloni govt Moody's on Friday left Italy's sovereign debt rating at Baa3, one notch above junk, but upgraded the outlook to stable from negative, in an unexpected boost for Prime Minister Giorgia Meloni's government.… https://t.co/CbADZ6VeSo https://t.co/yBbs58R29V